OtherEditorial
Viral Clearance Symposium 2017 Conclusion
Stefan Hepbildikler, Sarah A Johnson and Johannes Bluemel
PDA Journal of Pharmaceutical Science and Technology July 2018, pdajpst.2018.009084; DOI: https://doi.org/10.5731/pdajpst.2018.009084
Stefan Hepbildikler
1 Roche Pharmaceuticals;
Sarah A Johnson
2 FDA;
Johannes Bluemel
3 Paul-Ehrlich Institut Germany
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 2
March/April 2025
Viral Clearance Symposium 2017 Conclusion
Stefan Hepbildikler, Sarah A Johnson, Johannes Bluemel
PDA Journal of Pharmaceutical Science and Technology Jul 2018, pdajpst.2018.009084; DOI: 10.5731/pdajpst.2018.009084
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.